Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04617236
Other study ID # A1250312
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2012
Est. completion date July 2, 2020

Study information

Verified date October 2020
Source University of Puerto Rico
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of this education program is to increase breast and cervical cancer screening in low-income women in Puerto Rico through implementation of an evidence-based educational program that addresses both health professionals (promotoras or community health workers) and public audiences of low-income women living in Canóvanas, Puerto Rico who have either never been screened for breast and/or cervical cancer, or are under-screened according recommended guidelines. To evaluate promotoras' delivery of the CLS screening education program we used a randomized pre-post comparison group study design that will provide data to determine the effectiveness of the CLS intervention program compared with usual practice (no intervention).


Description:

The proposed promotora and community based breast and cervical screening education program includes the following specific aims: Aim 1. To train community health workers (promotoras) from Taller Salud to implement the CLS breast and cervical cancer screening program. Taller Salud staff train and build capacity of promotoras to implement the CLS community-based education and navigation program. Aim 2. To deliver the CLS intervention program to at least 600 women in Canóvanas municipality, Puerto Rico. Aim 3. To evaluate the impact of the program on increasing mammography and cervical cancer screening among participating women in Canóvanas, Puerto Rico. Aim 4. To adapt and update intervention materials


Recruitment information / eligibility

Status Completed
Enrollment 444
Est. completion date July 2, 2020
Est. primary completion date September 20, 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 21 Years and older
Eligibility Inclusion Criteria: - Women aged 21 and older for Pap cohort - Women aged 40 and older for Mammography cohort Exclusion Criteria: - Having completed a Papanicolau test in the past 3 years if participant is between the ages of 21-65. - Having completed a Mammography screening in the past year if participant is aged 40 or older - Have a hysterectomy - Currently pregnant - History of any type of cancer

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cultivando La Salud
A lay health worker delivered educational intervention for breast and cervical cancer screening. In total, the Intervention Group subject participation will take approx. up to four hours (1 hour for interview, 1 hour for the second interview, and 1-2 hours for the CLS intervention) and Control Group up to four hours (One hour for interview, one hour for the second interview, up to two hours for educational intervention after the second interview). Follow-up data was collected 4-6 months post education session (intervention group) or post-baseline survey (control group).

Locations

Country Name City State
Puerto Rico University of Puerto Rico, Medical Sciences Campus San Juan

Sponsors (2)

Lead Sponsor Collaborator
University of Puerto Rico The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

Puerto Rico, 

References & Publications (1)

Colón-López V, González D, Vélez C, Fernández-Espada N, Feldman-Soler A, Ayala-Escobar K, Ayala-Marín AM, Soto-Salgado M, Calo WA, Pattatucci-Aragón A, Rivera-Díaz M, Fernández ME. Community-Academic Partnership to Implement a Breast and Cervical Cancer S — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants aged 21 and older who completed a cervical cancer screening (Pap test) Screening behavior status at baseline and follow-up were assessed by asking women the month and year of their last Pap test. 4-6 months after the intervention
Primary Number of participants aged 40 and older who completed a mammography test Screening behavior status at baseline and follow-up were assessed by asking women the month and year of their last mammogram. 4-6 months after the intervention
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A